Laminate Medical Technologies is an Israeli therapeutic devices company based in Tel Aviv, specializing in medical technology for vascular access in hemodialysis patients. It develops VasQ, an external nitinol mesh support device implanted around arteriovenous fistulas (AVF) to improve maturation rates and patency. VasQ received CE Mark approval prior to 2023, FDA 510(k) clearance on 2023-09-27 for use in AVF creation, and FDA Breakthrough Device Designation in 2020. Ongoing clinical studies include the post-market study NCT06516653 and the prior VALUE trial NCT03246984. The company has raised approximately $38 million in funding across multiple rounds, including Series B and Series C.